Trademark Overview
On Friday, April 5, 2024, a trademark application was filed for ATARA with the United States Patent and Trademark Office. The USPTO has given the ATARA trademark a serial number of 98486779. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, April 5, 2024. This trademark is owned by Atara Biotherapeutics, Inc.. The ATARA trademark is filed in the Pharmaceutical Products category with the following description:
House mark for pharmaceutical and therapeutic preparations for the treatment of patients with chronic diseases, namely, cancer, kidney disease, diabetes, cachexia, age related sarcopenia, protein-energy wasting, and multiple sclerosis; pharmaceutical and therapeutic preparations for the treatment of autoimmune diseases and disorders; none of the foregoing to be used for pharmaceutical preparations for treatment of rheumatoid arthritis and psoriasis